Literature DB >> 28139036

Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors.

Shiteng Suo1, Fang Cheng1, Mengqiu Cao1, Jiwen Kang1, Mingyao Wang1, Jia Hua1, Xiaolan Hua1, Lan Li1, Qing Lu1, Jialin Liu2, Jianrong Xu1.   

Abstract

PURPOSE: To determine the utility of multiparametric diffusion-weighted imaging (DWI) including monoexponential (apparent diffusion coefficient [ADC]), biexponential (Df , Ds , and f), stretched-exponential (distributed diffusion coefficient [DDC] and α), and kurtosis (mean diffusivity [MD] and mean kurtosis [MK]) models in the differentiation and characterization of breast lesions, and assess their associations with prognostic factors in invasive breast cancer.
MATERIALS AND METHODS: This study included 101 patients (44 benign and 57 malignant lesions) who underwent 3T breast multi-b-value DWI. Diffusion model selection was investigated in benign and malignant lesions using the Akaike information criteria (AIC). Mann-Whitney U-test and receiver operating characteristic (ROC) curves were used for statistical analysis.
RESULTS: Goodness-of-fit analysis showed that most benign lesion voxels (50.5%) were preferred by the kurtosis model, and most malignant lesion voxels (51.2%) by the stretched-exponential model. All diffusion measures showed significant differences between benign and malignant lesions (P < 0.05), and between in situ and invasive cancers (P < 0.05) except MD (P = 0.103). There were no significant differences in areas under the ROC curves (AUCs) between ADC and non-monoexponential diffusion parameters (P > 0.05), except Df and α, whose AUCs were significantly lower than AUC of ADC for differentiating benign from malignant lesions (P = 0.03 and P < 0.01, respectively). In patients with invasive breast cancer, α was significantly correlated with tumor size (P = 0.007) and Ki-67 expression (P = 0.012), Df was significantly correlated with lymph node metastasis (P = 0.021) and Ki-67 expression (P = 0.042), and ADC, Ds , f, DDC, and MD were significantly correlated with estrogen receptor status (all P < 0.05).
CONCLUSION: Multiparametric DWI shows relationships with pathologic outcomes and prognostic factors of breast lesions. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:740-750.
© 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  breast; cancer; diffusion-weighted imaging; goodness of fit; magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28139036     DOI: 10.1002/jmri.25612

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  23 in total

1.  Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.

Authors:  Shiteng Suo; Dandan Zhang; Fang Cheng; Mengqiu Cao; Jia Hua; Jinsong Lu; Jianrong Xu
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

2.  Experimental factors are associated with fetal fraction in size selection noninvasive prenatal testing.

Authors:  Longwei Qiao; Jun Mao; Minjuan Liu; Yinghua Liu; Xiaoyan Song; Hui Tang; Qing Zhang; Hong Li; Yaojuan Lu; Yuting Liang; Ting Wang
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

3.  Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.

Authors:  Vivian Youngjean Park; Sungheon G Kim; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  Magn Reson Imaging       Date:  2019-07-16       Impact factor: 2.546

4.  Associations Between Dynamic Contrast Enhanced Magnetic Resonance Imaging and Clinically Relevant Histopathological Features in Breast Cancer: A Multicenter Analysis.

Authors:  Alexey Surov; Jin You Kim; Marco Aiello; Wei Huang; Thomas E Yankeelov; Andreas Wienke; Maciej Pech
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

5.  Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.

Authors:  Joao V Horvat; Manuela Durando; Soledad Milans; Sujata Patil; Jessica Massler; Girard Gibbons; Dilip Giri; Katja Pinker; Elizabeth A Morris; Sunitha B Thakur
Journal:  Eur Radiol       Date:  2018-01-12       Impact factor: 5.315

6.  An analysis of Ki-67 expression in stage 1 invasive ductal breast carcinoma using apparent diffusion coefficient histograms.

Authors:  Maolin Xu; Qi Tang; Manxiu Li; Yulin Liu; Fang Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

7.  q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity than Conventional Diffusion-weighted Imaging Methods at 3.0 T: A Pilot Study with Freshly Excised Whole-Breast Tumors.

Authors:  Nicholas Senn; Yazan Masannat; Ehab Husain; Bernard Siow; Steven D Heys; Jiabao He
Journal:  Radiol Imaging Cancer       Date:  2019-09-27

8.  Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.

Authors:  Jin Joo Kim; Jin You Kim; Hie Bum Suh; Lee Hwangbo; Nam Kyung Lee; Suk Kim; Ji Won Lee; Ki Seok Choo; Kyung Jin Nam; Taewoo Kang; Heeseung Park
Journal:  Eur Radiol       Date:  2021-08-04       Impact factor: 5.315

9.  Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.

Authors:  Shiteng Suo; Yan Yin; Xiaochuan Geng; Dandan Zhang; Jia Hua; Fang Cheng; Jie Chen; Zhiguo Zhuang; Mengqiu Cao; Jianrong Xu
Journal:  J Transl Med       Date:  2021-06-02       Impact factor: 5.531

10.  Evaluating the Histopathology of Pancreatic Ductal Adenocarcinoma by Intravoxel Incoherent Motion-Diffusion Weighted Imaging Comparing With Diffusion-Weighted Imaging.

Authors:  Qi Liu; Jinggang Zhang; Man Jiang; Yue Zhang; Tongbing Chen; Jilei Zhang; Bei Li; Jie Chen; Wei Xing
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.